User:Jessyyyyy227/Dopamine receptor D3/Bibliography

Reference

 * 1) Latif, S., Jahangeer, M., Maknoon Razia, D., Ashiq, M., Ghaffar, A., Akram, M., El Allam, A.. Dopamine in Parkinson's Disease. Clinica Chimica Acta 522, 114-126 (2021).
 * 2) Favier, M., Carcenac, C., Savasta, M. & Carnicella, S.. In Behavioral Neuroscience of Motivation (Behavioral Neuroscience of Motivation, 2022).
 * 3) Yang, P., Perlmutter, J. S., Benzinger, T. L. S., Morris, J. C. & Xu, J. Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment? Ageing Res. Rev. 57, 100994 (2020).
 * 4) Oliveira, V., Videira, G. & Mendes, A.. Loss of Awareness after Continuous Apomorphine Infusion Withdrawal in Parkinson's Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 47, 576–577 (2020).Wei, S., Yao, X., Wang, C., Dong, A., Li, D..  Pramipexole Regulates Depression-like Behavior via Dopamine D3 receptor in a Mouse Model of Parkinson's Disease. Brain Res. Bull. 177, 363-372 (2021).
 * 5) Sun, Y., Cui, B., Ye, L., Hu, Y. & Pan, Y.. Pramipexole Inhibits Neuronal Apoptosis in Rats with Parkinson's Disease. Journal of Healthcare Engineering 2022, 1–5 (2022).
 * 6) Mooney, E., Smith, M. D. & Henderson, E. J.. An Unwell Patient with Parkinson's disease: Hyperpyrexia Syndrome in a Heatwave. JRSM Open 13, 205427042210861 (2022).
 * 7) Zhang, J., Gao, X., Chen, Y. & Kong, Q.. Clinical Observation of Ropinirole Hydrochloride in the Treatment of Parkinson's Disease. Computational and Mathematical Methods in Medicine 2022, 1–7 (2022).
 * 8) Zhi, Y.. The Association between DRD3 Ser9Gly Polymorphism and Depression Severity in Parkinson's Disease. Parkinson's Disease 2019, 1–8 (2019).
 * 9) Krishnamoorthy, S., Rajan, R., Banerjee, M., Kumar, H., Sarma, G., Krishnan, S., Sarma, S., & Kishore, A. Dopamine D3 Receptor Ser9Gly Variant is Associated with Impulse Control Disorders in Parkinson's Disease patients. Parkinsonism & Related disorders, 30, 13–17 (2016).
 * 10) Castro-Martínez, X. H., García-Ruiz, P. J., Martínez-García, C., Martínez-Castrillo, J. C., Vela, L., Mata, M., Martínez-Torres, I., Feliz-Feliz, C., Palau, F., & Hoenicka, J. . Behavioral Addictions in Early-onset Parkinson's Disease are Associated with DRD3 Variants. Parkinsonism & related disorders, 49, 100–103 (2018).
 * 11) Rajan, R., Krishnan, S., Sarma, G., Sarma, S. P. & Kishore, A.. Dopamine Receptor D3 rs6280 is Associated with Aberrant Decision-Making in Parkinson's Disease. Movement Disorders Clinical Practice 5, 413–416 (2018).